Pasadena, CA, United States of America

Andy Y Tsai

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • City Of Industry, CA (US) (2005)
  • Pasadena, CA (US) (2019 - 2024)

Company Filing History:


Years Active: 2005-2025

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: Innovations by Andy Y Tsai in Glucose Monitoring Technology

Introduction

Andy Y Tsai is a prominent inventor based in Pasadena, CA, known for his significant contributions to the field of glucose monitoring technology. With a total of 14 patents to his name, Tsai has been instrumental in developing advanced methods and systems that enhance the accuracy and reliability of glucose sensors.

Latest Patents

Among his latest patents, Tsai has developed methods, systems, and devices for the calibration and optimization of glucose sensors. One notable innovation is a continuous glucose monitoring system that utilizes externally sourced information regarding the physiological state and ambient environment of its user. This system allows for the external calibration of sensor glucose measurements, improving accuracy without the need for blood-glucose calibration. Another significant patent involves an optional external calibration method for a calibration-free glucose sensor, which uses measured working electrode current and EIS data to calculate a final sensor glucose value. This method incorporates various models for predicting sensor glucose calculations, ensuring reliable output for users.

Career Highlights

Tsai's career is marked by his work at Medtronic Minimed, Inc., where he has played a crucial role in advancing glucose monitoring technologies. His innovative approaches have led to the development of systems that significantly improve the user experience for individuals managing diabetes.

Collaborations

Throughout his career, Tsai has collaborated with notable colleagues, including Keith Nogueira and Jeffrey Nishida. These collaborations have fostered an environment of innovation and have contributed to the success of various projects within the company.

Conclusion

Andy Y Tsai's work in glucose monitoring technology exemplifies the impact of innovation in healthcare. His patents and contributions continue to shape the future of diabetes management, providing users with more accurate and reliable tools for monitoring their health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…